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ABSTRACT 
Rhodococcus equi (R. equi) is an intracellular, gram-positive coccobacillus that 
causes pneumonia in foals aged 2 to 4 months. Neonatal foals are susceptible to R. equi 
infection probably due to inefficient Toll- like receptor (TLR)-2 signaling and inability to 
produce interferon gamma. One of the reasons for inefficient receptor signaling and 
recognition of R. equi by the foal’s immune system may be the inefficient sequestration 
of TLRs in lipid rafts, which act as signaling platforms. However, there are no protocols 
to isolate lipid rafts from equine cells and, therefore, no data on the association of TLRs 
with the lipid rafts in the lung cells of normal and infected foals. Because of the clinical 
importance of the disease, there is considerable interest in developing effective 
prophylactic methods, which in turn requires a better understanding of fundamental 
immunology of the foals. In this study, I have examined the effect of R. equi vaccination 
on the lung inflammation induced following challenge with R. equi. I also developed a 
protocol to isolate lipid rafts from broncho-alveolar lavage (BAL) cells and investigated 
the association of lipid rafts with TLRs.  
In the first study, 15 mixed breed draft-type foals up to 7 weeks of age were 
studied. The foals were divided into control (n=7) and a vaccinated (n=8). The control 
foals were given 10 mL phosphate buffered saline intramuscularly while the vaccinated 
group was vaccinated on day 0 of the study followed by a booster on day 14. All the foals 
were challenged with R. equi (5x106 cells/mL into the dorso-caudal region of the right 
lung lobe). BAL was performed on day 14, 28 and 35 and all the foals were euthanized 
on day 49 of the study.  
The study design did not leave any non- infected foal at the end of the experiment. 
Therefore, lung samples were obtained from two untreated control (non-vaccinated non-
infected) foals from the Department of Veterinary Pathology, University of 
Saskatchewan were used. The data showed similar levels of lung inflammation in both 
the control and vaccinated foal groups based on BAL cytology, gross pathology and 
histopathology. Gross and histopathological studies indicated that both control and 
vaccinated foals developed granulomatous lesions. Immunohistology showed increased 
expression of TLR4, TLR2 and TNFa in alveolar septa and in some cases in the vascular 
endothelium and airway epithelium in the lungs of both groups compared to the untreated 
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control foals. Western blots showed increased expression of TLR2 but not TLR4 in the 
lung extracts from both the vaccinated and the control foals. Vaccinated foals showed 
higher concentrations of TNFa (p=0.0219) in their BAL on day 28 but lower 
concentrations of IL-10 (p=0.0172) in their lung extracts collected on day 49 compared to 
the controls. There were no differences in IFNg and protein concentrations between the 
two groups. 
To understand the role of lipid rafts in TLR4 and TLR2 signaling, I developed an 
efficient and simpler protocol to isolate lipid rafts from BAL cells of foals and confirmed 
their identity by localizing Flotillin-1 and GM-1 (fractions 6-9), which are lipid raft 
markers, and transferrin receptor (fractions 1-4) which is present in non- lipid raft  
fractions. Lung macrophages from naïve foals lacked sequestration of Flotillin-1 and 
GM-1 in the higher fractions compared to the vaccinated foals. Further, the data showed 
that while TLR4 and TLR2 were localized in most of the fractions (1-9) in control foal 
BAL collected on day 14 and 28, the TLR4 and TLR2 association was restricted to 
fractions 6-9 in the lipid rafts isolated from BAL cells of vaccinated foals. These data 
suggest that BAL cells of neonatal foals may not have effective signaling machinery 
because of lack of association of TLR2 and TLR4 with lipid rafts.  
Taken together, the data show similar levels of lung inflammation in the control 
and vaccinated foals upon infection with R. equi. The vaccination, however, appeared to 
have some effect on the immunohistologic expression of TLR2, TLR4 and TNFa in the 
lung tissues, and increased association of TLR2 and TLR4 with the lipid raft fractions. 
Based on the higher expression of TNFa and lower expression of IL-10, the vaccinated 
foals may be more competent to mount an immune response against R. equi.  
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CHAPTER 1: INTRODUCTION 
 
Animals regularly encounter pathogens that are eliminated by a complex set of immune 
mechanisms. The immune system consists of two compartments called the innate (natural/native) 
and the adaptive (acquired) immune systems. The innate immune response is short lived and 
retains no memory of exposure to antigen. The adaptive immunity encompasses the defense 
mechanisms providing protection against various pathogens encountered during life and 
recognizes them on subsequent exposure (Giguere et al., 2005). 
Granulocytes, also called polymorphonuclear cells (PMN), and macrophages play pivotal 
roles in protection against infections immediately after birth. Foals are immune-competent at 
birth although transfer of maternal immunoglobulin to the fetus is restricted by the 
epitheliochorial placentation (Giguere et al., 2005). However, at birth foals do not have fully 
functional lymphoid tissue and macrophages lack phagocytic functions (Giguere et al., 2005). 
Although the pulmonary immune defense system develops much slower than peripheral blood 
cells (Giguere et al., 2005), it acts as a reservoir for recruitment of a greater number of 
lymphocytes (T and B lymphocytes) than peripheral blood (Blunden et al., 1999). It is believed 
that lack of a fully functional immune response makes foals susceptible to infection by various 
bacteria and viruses.  
Rhodococcus equi (R. equi), a gram positive coccobacillus, is a facultative intracellular 
bacterium that causes pulmonary infections in foals resulting in pyogranulomatous lesions 
(Darrah et al., 2004; Muscatello et al., 2009). It is believed that foals between 2-4 months of age 
are most susceptible to disease caused by R. equi infection (Prescott, 1991; Giguere et al., 1997; 
Chaffin et al., 2003). As well, R. equi has been identified as an opportunistic pathogen of 
environmental origin, which can infect immunocompromised humans (Perez et al., 2002; Meijer 
et al., 2004; Muscatello et al., 2009). The impact of R. equi pneumonia on the equine industry is 
significant (Toyooka et al., 2005). In the United States, respiratory disease ranked as the third 
most common cause of disease in foals less than 6 months of age (Anonymous, 2006). To date, 
there is no effective vaccine available against R. equi infection (Lopez et al., 2002). R. equi has 
the ability to persist, replicate within macrophages and kill them (Hondalus et al., 1994) due to 
mycolic acid-enriched lipids in the cell wall (Barry et al., 1998; Meijer et al., 2004). We lack a 
precise understanding of immune responses in foals infected with R. equi with or without 
vaccine. 
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The cell membrane is a semi-permeable lipid bilayer. It is comprised of a variety of 
biological molecules, primarily proteins and lipids, which are involved in a vast array of cellular 
processes such as ion conductance, cell adhesion and cell signaling. The cell membrane contains 
cholesterol and glycosphingolipid-rich microdomains called lipid rafts. Lipid rafts are a few 
nanometers to a few hundred nanometers in diameter (Pralle et al., 2000; Hancock, 2006), and 
are heterogeneous and dynamic microdomains that compartmentalize cellular processes. They 
are enriched in cholesterol, sphingolipids and transmembrane proteins and represent up to 50% 
of the cell membrane (MacDonald, 1980; Hanada et al., 1995; Fridriksson et al., 1999; Brown et 
al., 2000; Horejsi, 2003). Lipid rafts play a key role in cell signaling, activation of monocytes 
and macrophages, and normal functioning of the digestive, respiratory and immune system 
(Drevot et al., 2002). Foals are susceptible to many pulmonary diseases and there is no 
information on the lipid rafts in their cells such as alveolar macrophages which are central to 
pulmonary immune responses. There are no data on the isolation of lipid rafts and association of 
TLR2 and TLR4 with lipid rafts from foal lung lavage. Because of the role of TLR2 in the 
engagement of R. equi by alveolar macrophages (Darrah et al., 2004), it is important to 
understand the role of alveolar macrophage lipid rafts in the aggregation of TLR2 and 
subsequent interactions with R. equi.  
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CHAPTER 2:  LITERATURE REVIEW 
 
 
2.1.     Prevalence and significance of R. equi infection in foals 
R. equi is gram positive coccobacillus, facultative intracellular bacterium that has been 
known as a pulmonary pathogen of horses for more than 80 years (Vyslouzil et al., 1984). R. 
equi causes pyogranulomatous (Darrah et al., 2004; Muscatello et al., 2009) pneumonia in foals 
between 2 and 4 months of age (Zink et al., 1986; Yager, 1987; Prescott, 1991; Giguere et al., 
1997; Chaffin et al., 2003). R. equi has been identified as an opportunistic pathogen of 
environmental origin, which can infect immunocompromised humans, especially AIDS patients 
(Prescott, 1991; Drancourt et al., 1992; Mosser et al., 1996; Perez et al., 2002; Meijer et al., 
2004; Muscatello et al., 2009). The impact of R. equi pneumonia on the equine industry is 
significant (Toyooka et al., 2005). 
 
2.2.     Ecology  
           Different geographic areas possess different R. equi serotypes (Makrai et al., 2008).  
There is high density (17.3 times) of this bacterium in densely populated stables compared to 
paddocks (Muscatello et al., 2006) and soil contaminated with herbivore manure, as the 
bacterium has a predilection for volatile fatty acids (Prescott, 1991), and in stables with poor 
ventilation especially in warm climates (Prescott, 1991; Hondalus,1997; Prescott et al., 1997; 
Giguere et al., 1999; Muscatello et al., 2006; Cohen et al., 2008; Flaminio et al., 2009). 
However, bacteria can also be transmitted from the breath of infected foals (Muscatello et al., 
2009). Infection rates of 1-10% and a mortality of less than 1% has been reported from 
Australian farms while nearly 47% of 138 horse breeding farms in the USA were found to be 
infected (von Bargen et al., 2009). The incidence of infection increases mostly in summer 
climate when the temperature is favorable for the growth of bacteria, the dusty environment 
initiates the aerosol transport of contaminated dust particles (Meijer et al., 2004) and the soils are 
favorable for growth of bacteria (Muscatello et al., 2006). Manure acts as reservoir of infection 
as the volatile fatty acids present in equine feces enhance the replication of R. equi by 10,000 
fold (Hughes et al., 1987) and the bacteria are recovered from the intestinal tract of healthy 
horses (Woolcock et al., 1980).  
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The surrounding environment, higher foal density and increased numbers of transiently 
infected mares play an important role in the spread of infection (Grimm et al., 2007). Infected 
foals shed higher numbers of R. equi in their feces compared to the adult horses, and this 
shedding is the major cause of contamination of the soil (Prescott et al., 1984). After 7 weeks of 
age, the shedding is reduced because of the development of gut immunity (Takai et al., 1986). R. 
equi exists in virulent and non-virulent strains, and the virulent strain is characterized by its 
ability to persist, replicate within alveolar macrophages and kill them (Hondalus et al., 1994). 
Survival of R. equi is dependent upon carbon from lipids (Vazquez-Boland et al., 2009) and 
organic acids such as proprionate or acetate (Hughes et al., 1987) derived from herbivores 
manure (Barton et al., 1984; Prescott, 1987).  R. equi also requires low levels of divalent cations 
such as iron (Fe 2+), calcium (Ca2+), magnesium (Mg 2+) for its survival and expression of VapA 
on its surface (Takai et al., 1992; Takai et al., 1996; Benoit et al., 2001; Benoit et al., 2002; 
Jordan et al., 2003; Ren et al., 2003)  The primary route of infection is inhalation of dust 
particles from surroundings that are contaminated with R. equi from feces (Takai et al., 1986; 
Prescott,1991; Mosser et al., 1996; Muscatello et al., 2009). Prolonged oral exposure to R. equi 
leads to intestinal lesion in infected foals (Johnson et al., 1983).  
R. equi is endemic on certain farms and sporadic on many farms. There is considerable 
variation in the severity and prevalence of this disease. Recent epidemiological data have shown 
no relationship between preventive measures such as use of hyper-immune serum and prevalence 
of disease due to R. equi (Muscatello et al., 2007).  
 
2.3.     Clinical signs  
The classical form of the disease, commonly referred as “rattles”, was mostly observed in 
the past and only in the highly advanced cases of disease. This particular manifestation shows 
high fever, increased counts of neutrophils in broncho-alveolar lavage (BAL) and mucus and 
purulent discharge from the nostrils (Muscatello et al., 2007). Infection with R. equi is most 
commonly characterized by a subacute to chronic bronchopneumonia. Foals in the early stages of 
the disease show fever (rectal temperature 38.8-400C, up to 410C), increased respiratory rate, 
nasal discharge, neutrophil infiltration into the lungs and formation of giant cells. The advanced 
stages of the disease show necrosis in the pulmonary parenchyma, development of 
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granulomatous lesions, infection of lymph nodes, and along with these signs, some foals also 
suffer from severe diarrhea with ulcerative enteritis (Cimprich et al., 1977; Zink et al., 1986; 
Yager,1987; Prescott,1991; Giguere et al., 1997). On auscultation, abnormal lung sounds such as 
inspiratory and expiratory wheezes and crackles are audible in foals infected with R. equi 
(Giguere et al., 1997). Furthermore, about 50% of R. equi infected foals showed intestinal 
manifestations, characterized by typhlitis and multifocal ulcerative enterocolitis along with 
granulomatous or suppurative inflammation of mesenteric and colonic lymph nodes (Zink et al., 
1986). In the chronic phases of the disease, peritonitis may result and R. equi can be isolated 
from the peritoneal fluid (Morton et al., 2001). Infected foals may show stiff gait due to 
development of septic arthritis/osteomyelitis, especially in the tibiotarsal and stifle joints 
(Sweeney et al., 1987). Other immune mediated conditions such as uveitis may also develop. 
The total white blood cell count (≥13,000/µL) and serum fibrinogen concentration (≥600mg/dL) 
are indicative of severe infections and should prompt further diagnostic testing (Heidmann et al., 
2006).  
Depending upon the clinical manifestation, for diagnosis fecal culture and abdominal 
ultrasonography are helpful for diagnosis (Chaffin et al., 2003). However, bacterial cultures from 
tracheobronchial exudates and cytological examinations are more reliable tools (Giguere et al., 
1997).  
 
2.4.      Vaccination against R. equi 
Antibiotic therapy for the disease caused by R. equi is not effective in all the foals and is 
prolonged and expensive. So, there is a need to develop an effective vaccine against R. equi 
infections. It is clearly understood that neither heat killed nor DNA-based vaccines are effective 
against R. equi infection (Lopez et al., 2003; Taouji et al., 2004; Haghighi et al., 2005) . 
Vaccination strategies against R. equi are still under investigation especially in young foals as 
successful immunization against R. equi is not yet developed (Pei et al., 2007; Lopez et al., 
2008). Both innate and acquired immune mechanisms are required to clear R. equi infection. 
Therefore, live attenuated vaccines might be an effective strategy of protection against this 
infection (Muscatello et al., 2007). Some protection against experimental Rhodococcus infection 
in mice has been demonstrated by the use of a attenuated strain of Salmonella expressing VapA 
protein (Oliveira et al., 2007).  
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2.5.       Pathogenesis involved in R. equi infection 
      Foals are exposed to R. equi through various routes such as the respiratory (most common 
route), intestinal and genital route (Yager, 1987). In the early stages of disease development 
following oral route of infection, the bacteria reside in the intestine of the infected foals (Takai et al., 
1986). Following inhalation of the bacterial, alveolar macrophages form the first line of defense 
along with the epithelial lining of the airways. The phagocytosis of R. equi by the alveolar 
macrophages is increased in the presence of opsonins and complement fragments (von Bargen et al., 
2009). The bacteria are transported into lysosomes leading to the development of phagolysosomes. 
The bacteria are killed through the activation of various hydrolytic enzymes (proteases) at low pH in 
the phagolysosomes and through the actions of reactive oxygen species (hydrogen peroxidases, nitric 
oxide, superoxide radicals) (Haas, 2007). Through multiple mechanisms, some still to be fully 
elucidated, R. equi manages to evade these usually potent anti-bacterial mechanisms in the 
macrophages. The phagosomes containing virulent R. equi mature normally but lose early markers 
such as cathepsin-D followed by appearance of late molecular markers such as lysosomal associated 
marker protein 1 (LAMP-1).  These R. equi containing vacuoles do not proceed to late endocytic 
organelles, nor do they fuse with lysosmes or acquire proton-pumping vacuolar ATPase (Fernandez-
Mora et al., 2005; Toyooka et al., 2005). This allows the bacteria to escape toxic enzymes and 
continue replication inside the cells (Takai et al., 1985; Samies et al., 1986; Hietala et al., 1987). The 
survival of R. equi is due to the presence of a lipid rich cell wall, especially enriched in mycolic 
acids, which shield it from adverse environmental conditions such as oxidative stress and low pH 
within macrophages (Barry et al., 1998; Meijer et al., 2004). As the disease progresses, the vacuoles 
containing the bacteria become multilobed and filled with vesicles, but still remain intact 
(Fernandez-Mora et al., 2005). After 8 hours of infection, degradation of the host cell occurs, 
releasing lysosomal material into macrophage cytoplasm and thereby causing macrophage necrosis 
(Zink et al., 1987; Hondalus et al., 1994; Luhrmann et al., 2004) and granuloma formation in the 
lungs (Luhrmann et al., 2004; Meijer et al., 2004). The presence of R. equi in the lungs in the early 
stages of disease leads to inflammation characterized by the migration of neutrophils and monocytes 
followed by development of giant cells (Johnson et al., 1983). With progression of the disease, the 
lung parenchyma becomes necrotic, followed by affection of bronchial and mesentric lymph nodes 
(Zink et al., 1986; Yager, 1987). Neutrophils are effective in killing extracellular bacteria and link  
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the innate and adaptive immunity (Meijer et al., 2004; Nerren et al., 2009). Neutrophil migration  
into the lungs is regulated through the expression and engagement of adhesion molecules in the lung 
capillaries; these processes have not been investigated in horses (Lazarus, 1986; Downey et al., 
1993; Guo et al., 2002; Soethout et al., 2002). Shortly after the onset of vascular changes, the 
migrated neutrophils initiate phagocytic activity and thus release enzymes that damage the tissue, 
induce production of chemokines to attract  more inflammatory cells, and produce pro-inflammatory 
cytokines (TNFα, IL-1α, IL-1β, IL-6)  to increase inflammation at the site of injury (Thacker, 2006). 
On the other hand, macrophages and other cells of the immune system such as fibroblasts and airway 
epithelial cells also become activated and release proinflammatory cytokines and increase the 
expression of adhesion molecules for chemotaxis of neutrophils and monocytes, and thereby further 
increase the inflammatory response (Thacker, 2006). 
 There are seven different types of 80 to 90-kb plasmid, such as VapA and VapC to VapH (Takai 
et al., 2000) in R. equi. The major virulence factor associated with R. equi is the lipid-modified 
virulence-associated protein A (VapA) (Takai et al., 2000), which is expressed on the bacterial 
surface as proved by its susceptibility to trypsin digestion (Lazarus,1986; Burns et al., 1996; 
Murtaugh et al., 1996), especially between 34°C and 41°C. Plasmid cured derivates of R. equi 
strains become unable to replicate and persist inside macrophages (Giguere et al., 1999) and are 
incapable of inducing pneumonia in foals as they are easily cleared by pulmonary immune defense 
mechanisms (Wada et al., 1997; Giguere et al., 1999). On the other hand, VapA can induce 
activation of Toll-like receptor 2 (TLR2) and is essential for the replication of the bacteria inside the 
macrophage, which is one of the most important mechanisms employed by R. equi to evade the host 
immune response  (Jain et al., 2003; Darrah et al., 2004). Interestingly, there is evidence of enhanced 
susceptibility of neonatal foals to R. equi due to inefficient TLR2 signaling and activation of NF-B 
and production of inflammatory cytokines (Darrah et al., 2004). The ability of R. equi to persist in 
macrophages is fundamental to its escape from elements of the pulmonary defense (Giguere et al., 
1999; Jain et al., 2003; Meijer et al., 2004;Takai et al., 1985; Samies et al., 1986; Hietala et al., 
1987). The low number of resident alveolar macrophages (Zink et al., 1984) and their reduced ability 
to kill bacteria (Zink et al., 1985) may contribute to a higher incidence of R. equi infection in young 
foals (less than 20 days).  
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2.6.        Pulmonary immune response to R. equi infection 
It is generally accepted that the immune system in the lungs of young foals is not fully 
developed compared to adult horses. However, precise information on the specifics of immune 
system development in foals is not available. Foals mount a type 2 immune response and are 
susceptible to R. equi infection (Boyd et al., 2003; Hooper-McGrevy et al., 2003; Breathnach et al., 
2006). Foals with a mature immune system can resist and clear R. equi infection (Mosser et al., 
1996). Expression of IFNγ in foals starts at 1 week of age and reaches its peak level at 
approximately 3 months of age (Breathnach et al., 2006). Thus, susceptibility to intracellular 
pathogens such as R. equi is likely due to the inability of foals to mount an adequate Th-1 immune 
response and also due to lack of TLR 2 expression on alveolar macrophages (Darrah et al., 2004).  In 
addition, the role of cell-mediated immunity is important in clearance of R. equi (Mosser et al., 
1996), and there is a requirement for a balanced Th-1 (cell mediated) and Th-2 (humoral) immune 
response (Hines et al., 1997). T cell-mediated immunity plays a significant role in the clearance of 
intracellular bacteria through cytotoxicity against infected cells (macrophages). There is an increase 
in expression of pro-inflammatory cytokines such as TNFα and anti-inflammatory cytokines (IL-10, 
and IL-12), while expression of IFNγ remains unaltered in foals infected with a virulent strain of R. 
equi (Giguere et al., 1999). These cytokines play a significant role in cell to cell communication as 
they act as signaling molecules (Benton et al., 1988). 
Pulmonary alveolar and intravascular macrophages in the horse lung produce 
inflammatory cytokines such as TNFα and IL-1 (Baarsch et al., 1991; Parbhakar et al., 2005). 
Inflammatory cytokines are produced by activated cells and these cytokines in turn activate 
phagocytic cells to eliminate bacteria. However, excessive levels of TNFα are detrimental to the 
health of the individual as increased levels lead to severe damage to the lung parenchyma, 
cardiopulmonary shock and eventually death of the animal (Cohen, 2002; Parbhakar et al., 
2005). These cytokines activate endothelium, induce increased expression of adhesion molecules 
and lead to recruitment of inflammatory cells such as neutrophils (Benton et al., 1988; Murtaugh 
et al., 1996; Stylianou et al., 1998). TNFα induces the production of IL-6 from macrophages, 
fibroblasts, endothelial cells and smooth muscle cells (Cohen, 2002). IL-6 stimulates acute phase 
response proteins such as increased levels of transferrin and regulates the specific humoral  
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immune response (Muraguchi et al., 1988; Takatsuki et al., 1988; Van Snick et al., 1988; 
Murtaugh et al., 1996). Depending upon the inflammatory stimulus by R. equi and immune 
response of the host, granulomas, fibrin deposition, hypertrophy of smooth muscle and 
bronchoconstriction occurs (Schluger, 2005).  
Although considerable progress has been made in our understanding of pathogenesis of 
R. equi infection in the foals, the exact mechanisms underlying the ability of R. equi to infect 
foals and the inability of foals to eradicate the bacteria are not known. One of the possibilities 
may be the ability of R. equi to “silently” enter the macrophages or the immaturity of monocytes 
and macrophages in the lungs of foals to recognize R. equi. Recent evidence has alluded to the 
role of TLR2 in the engagement of R. equi and activation of immune cells (Darrah et al., 2004). 
The mere presence of TLR2 on plasma membrane is not sufficient to activate the cells. There is a 
requirement that TLR2 molecues are brought in close proximity through the actions of lipid rafts 
for effective recognition of microbial threat, cell activation and appropriate immune response.   
 
2.7.     Structure of lipid rafts: Biochemical components and size 
 The plasma membrane contains 26% phosphatidylcholine, 24% sphingomyelin, and 12% 
glycosphingolipids and consists of various adhesion structures such as the cellular synapses, cell 
to cell junctions and membrane invaginations such as caveolae and clathrin coated pits (Hietala 
et al., 1987; Zink et al., 1987). Caveolae are stable flask shaped invaginations of the plasma 
membrane found in various cell such as endothelial cells and adipocytes. They are rich in 
proteins and lipids (cholesterol and sphingolipids), contain 100-200 regulatory proteins such as 
caveolin-1(cav-1) and play a significant role in signal transduction (Acosta-Perez et al., 2008; 
Lajoie et al., 2009). Cav-1 regulates lipid raft dependent endocytosis (Parton et al., 2007). Lipid 
rafts are plasma membrane domains, enriched in cholesterol, glycosphingolipids and 
transmembrane proteins (MacDonald, 1980; Hanada et al., 1995; Fridriksson et al., 1999; Brown 
et al., 2000; Horejsi, 2003) found in all cells (Fig.2.1.).  Lipid rafts are insoluble in cold 
detergent extraction and therefore are also known as detergent-insoluble glycolipid-enriched 
complexes (DIGs) or the detergent resistant membrane (DRM) (Schuck et al., 2003). Lipid raft 
size is usually in the nanometer range (10-200 nm), and lipid rafts have a complex biochemical 
structure and are transient in nature. One of the functions of lipid rafts is to compartmentalize 
cellular processes (Hancock, 2006; Lajoie et al., 2007). There are no data on the actual area of  
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cell surface occupied by lipid rafts (Hancock, 2006). Lipid rafts play a key role in the activation 
of monocytes and macrophages as many receptors and signaling proteins are present in and are 
aggregated by the lipid rafts. Also, major histocompatibility complex-I is associated with DRM 
as it interacts with proteins such as Ganglioside asialo (GM1) (Shaw, 2006). Lipid rafts are 
tightly packed because of the saturated hydrocarbon chains (Brown et al., 2000; Rodgers et al., 
2005; Knorr et al., 2009). Many proteins such as CD14, which are important in endotoxin-
induced cell activation, are tethered via the glycosylphosphatidylinositol molecule on the outer 
layer of the cell membrane (Chatterjee et al., 2001; Triantafilou et al., 2002; Sharom et al., 
2004). There are examples of anchoring of signaling proteins such as Src-family kinases (e.g. 
Lck, Fyn and Lyn) to the inner leaflet via dual acylation modification (Brown et al., 2000) and 
myristoylation (Bickel et al., 1997; Simons et al., 2000; Rajendran et al., 2003). The outer shell 
of the membrane consists of sphingolipid and cholesterol, which is connected to the inner shell, 
composed of phospholipids and cholesterol, through a lipid bilayer (Rajendran et al., 2003).  
This arrangement of proteins in the lipid rafts leads to formation of physical platforms to link the 
outside of the cell with the signaling pathways inside of the cell (Brown et al., 1998; Simons et 
al., 1999; Simons et al., 2000). This association is brought about through clustering of lipid rafts 
and quickly brings proteins into proximity of each other and speeds up cell signaling and 
generation of an inflammatory response (Simons et al., 2000). In addition to the role of lipid rafts 
in inflammatory responses, the rafts are also implicated in the normal physiology of digestive, 
respiratory and immune systems (Simons et al., 2002). 
There are no data on lipid rafts in foal tissues. Because of the susceptibility of foals to 
many respiratory diseases such as endotoxin-associated lung inflammation and pneumonia 
caused by infections such as R. equi, and considering the importance of lipid rafts in TLR-
induced inflammatory cell signaling, it is important to develop protocols to isolate lipid rafts 
from alveolar macrophages of foals and to study their association with TLRs in normal and 
inflamed lungs.  
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HYPOTHESIS 
• Vaccination against R. equi will reduce lung inflammation in foals challenged with R. 
equi. 
• Lipid rafts associate with TLR2 and TLR4 in lung tissues and broncho-alveolar lavage 
cells of foals. 
 
OBJECTIVES 
The study was undertaken to investigate the following objectives. 
 
1. To examine lung inflammation in control (non-vaccinated + R. equi challenge), 
vaccinated (vaccinated + R. equi challenge), untreated control foals. 
2. To examine the expression of TNF, IL-10 and IFN in BAL supernatants and lung 
tissues (vaccinated foals and control foals) 
3. To examine the expression of TLR2 and TLR4 in lung tissues (untreated controls foals, 
vaccinated foals and control foals). 
4. To develop protocol for the isolation of lipid rafts from broncho-alveolar lavage (BAL) 
cells of foals. 
5. To study the association of TLR2 and TLR4 with lipid rafts isolated from BAL cells of 
foals. 
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CHAPTER 3: MATERIALS AND METHODS 
 
   3.1. Animals  
All procedures were approved by University of Saskatchewan Animal Research Ethics 
Board and conducted in compliance with the guidelines of the Canadian Council on Animal Care 
(CCAC). A total of 15 mixed breed draft-type foals up to 7-weeks of age were used in this study. 
Foals were born healthy and normal between May 09, 2008 (foal 1) and June 06, 2008 (foal 15). 
They were kept together in one pen along with their mares, with free access to grass hay and 
water throughout the study (Figure 3.1). Routine physical examination that included body 
weight, heart rate and rectal temperature were performed on days 0, 14, 28, 35 and 49. 
Respiration rate was monitored twice daily. All animals were subjected to euthanasia by an 
overdose of Euthanyl (Pentobarbital Sodium) at the end of the study. 
 
3.2.       Vaccine 
 Each vaccine dose contained 100 g of rVapA, 2.5 g of CpG ODN (class C, ODN 2395), 
4 mg carbopol and 10% (v/v) Emulsigen in a total of 10 ml PBS. Control foals received 10 ml 
PBS. All vaccines and control injections were given intramuscularly. 
 
    3. 3. R. equi culture 
 R. equi 103+ (virulent strain) was kindly provided by Dr. J. Prescott (Department of 
Pathobiology, University of Guelph, ON, Canada). It possesses an 80.6 kb virulence-associated 
plasmid encoding for virulence-associated protein A (VapA) and other virulence-associated 
protein genes. The bacterial culture was grown in Phytone media supplemented with riboflavin 
(BBLTM Phytone TM Peptone, BD, Sparks, MD, USA) for 16 h at 37◦C in an orbital shaker. 
The final concentration of 5x106  bacteria/mL was achieved after re-suspending the bacteria in 
PBS and stored at −80◦C. Before each treatment, serial dilutions of bacterial culture were plated 
on BHI plates with 1.5 % agar and colony forming units (CFU)/mL were calculated.  
 
3.4. Study design 
 The study plan is summarized in Figure 3.2. Fifteen foals aged up to 7-weeks were 
divided into two groups. All of the even numbered foals (n=7; foal numbers 2, 4, 6, 8, 10, 12 and  
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14) represented the control (non- vaccinated) group and were given 10 mL PBS intramuscularly. 
All the odd numbered foals (n=8; foal numbers 1, 3, 5, 7, 9, 11, 13 and 15) represented the 
vaccinated group. Foals were between 0-6 days of age on day 1 of the study and were euthanized 
on day 49. The foals were examined for weight, rectal temperature, heart rate, respiratory rate, 
presence of cough, quality of lung sounds on inspiration and expiration and colour of oral 
mucous membranes on day 0, 14, 28, 35 and 49. Foals that developed unexpected clinical signs 
such as colic were separated from the group with their dams, examined thoroughly daily and 
treated as necessary or euthanized. With the exception of one foal (foal number 4), all foals 
completed the study. Foal 4 showed depression, colic and abdominal distension on day 42 and 
was euthanized on day 45. 
The first vaccination against R. equi was given on day 0 (Vaccination 1), when foals were 
between 1 and 6 days of age. The booster was given 14 day after the first vaccination at the time 
of the first bronchoalveolar lavage (BAL). On day 28, the second BAL was performed and 
animals were challenged intra-bronchially with R. equi (5x106 cells/mL into the dorso-caudal 
region of the right lung lobe). The third BAL was collected on day 35. All the foals were 
subjected to euthanasia on day 49 to examine gross, histopathological and immunohistological 
changes in the lungs.  
 
3.5.      Lung tissue sampling 
The different experiment groups were summarized in table 3.1 and figure 3.2. Both left 
and right lung lobes were analyzed grossly, weighed and photographed (dorsal and ventral 
views). The lung lobes were sectioned at three regions: section 1 mid-way along the length of the 
cranial lobe; section 2 at the level of the hilus; and section 3 half-way between the hilus and the 
caudal extent of the lobe. Although the challenges were done in only right lung, the 
histopathology showed inflammation in both the lungs. Therefore, the untreated control foal lung 
samples (n=2) were kindly provided by Dr. Andrew Allen, Department of Veterinary Pathology, 
University of Saskatchewan for lung histopathology, immunohistology and confocal studies. One 
of the foals (N95-1884) was a normally developed female foal, born on April 26, 1995, at about 
336 days of gestation and euthanized between 4 and 10 hours after birth. The pregnant dam has 
undergone general anesthesia 132 days prior to parturition. The other foal (N95-2813) was a  
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normally developed female foal, born on July 8, 1995, at about 331 days of gestation and 
euthanized about 5 hours after birth. 
The pregnant dam would have undergone general anesthesia 115 days prior to parturition 
and both the dam and fetal foal in both cases of foals has undergone abdominal surgery and 
received a variety of drugs, including antibiotics.  
Lung sections were photographed and scored according to the following criteria: Normal 
(score 0) = Absence of lesions and no inflammation; Mild (score 1) = A few, widely scattered 
foci of inflammation; Moderate (score 2) = many clustered, small foci of inflammation or 
accompanied by congestion and abscess; Severe (score3) = large (50mm or greater) foci of 
inflammation accompanied with severe lung inflammation.  
 
 
3.6. Bronchoalveolar Sampling  
Table 3.1 shows the BAL sampling plan. Foals were sedated with 0.2-1.0 mg/kg xylazine 
(Novopharma, Markham, ON, Canada) intravenously, followed by induction with 2 mg/Kg 
ketamine (Wyeth-Ayerst, Saint-Laurent, QC, Canada) and 0.1 mg/Kg Diazepam (Sandoz, 
Boucherville, QC, Canada). After induction, an 18 gauge 1.5 inch sterile catheter was placed in a 
jugular vein. In order to prolong the duration of the anesthesia and to prevent coughing, 0.02 
mg/Kg Butorphanol (Wyeth-Ayerst,) was given intravenously. Anesthesia was maintained with 
ketamine and diazepam (1/4 to 1/2 of the induction dose) or triple drip. Supplemental oxygen (2-
5 L/min) was given to foals via a nasal tube during the collection of BAL to maintain oxygen 
saturation level above 95%. Various physical parameters such as heart rate, respiratory rate, 
colour of mucus membrane, capillary refill time, pulse quality and depth of anesthesia were 
monitored.  
A 3m video-endoscope (Olympus SIF-100, Olympus Canada Inc., Markham, ON, 
Canada) was passed intranasally and directed into the left lung to lavage it first by instilling 
500mL of warm sterile PBS solution (0.9% sodium chloride, 0.06% sodium bicarbonate, pH 6.5 
Abbott Laboratories, Saint-Laurent, QC, Canada) at 37°C followed by the right lung. 
Immediately after BAL2 at day 28 (on the day of challenge),  
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Figure 3.1.  Photo showing housing of foals along with their mares  
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we lavaged the left side first followed by the right side, then challenged the right caudal lobar 
bronchus intrabronchially with 10 mL of PBS containing 5x106 R. equi.The endoscope was 
flushed with 50 mL of air just before removal. The aspiration of BAL fluid was done using a 
vaccum pump (Millipore GE, Mississauga, ON, Canada) that directed the fluid into sterile flasks 
on ice for further analysis (Figure 3.3). The total volume of BAL fluid administered and 
recovered was recorded. Foals were kept under observation. Once able to stand and walk, they 
were returned to their dams. 
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Control group (saline + R. equi infection) 
Vaccinated group (vaccine + R. equi infection) 
 
 
Figure 3.2. Summary of study plan 
 
 
 
 
 
0                   14 28 35 49 
Timeline (days)
Vaccination 1 
(V1)/ saline    
 BAL1/V2              BAL2 BAL3 Necropsy
Intrabronchial Challenge
5X10 6 CFU/mL 
R. equi 103+
 18
 
 
 
 Figure 3.3. An endoscope with a suction pump 
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BAL Sampling BAL Experiment Groups 
BAL 1 on day 14  
 Vaccinated group (Vaccine + R. equi) n=8  
 Control group (Saline + R. equi) n=7  
BAL 2 on day 28 
BAL 3 on day 35  
 
 
 
Lung Sampling Experiment Groups 
Histopathology Untreated control (non-vaccinated, non-infected)  
group (n=2)  
Vaccinated group (Vaccine + R. equi) n=8  
Control group (Saline + R. equi) n=7   
Immunohistochemistry 
      
Confocal microscopy  
 
Untreated control foal group (n=2)  
 
                             Table 3.1. Summary of BAL and lung experiment groups  
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3.7. Differential cell count 
 Total nucleated cell counts (TNCC) were determined by using a hemocytometer (Fischer 
scientific, Ottawa, ON, Canada). The differential cell counts were determined by examination of 
cytospin preparations, stained with Trypan blue, and counting 100 leukocytes in a microscopic 
field (40X). 
The BAL cells (right lung) were washed with RPMI-1640 medium (Invitrogen, 
Burlington, ON, Canada), supplemented with 2 mM L-glutamine, 10% fetal bovine serum 
(Invitrogen) and 5 µg/mL gentamicin (Invitrogen) and were centrifuged at 400g for 10 min at 
10C. The pellet was re-suspended in 10 mL of supplemented RPMI-1640. Cells were grown in 
a sterile plastic culture flask (VWR, international, LLC, Edmonton, AB, Canada) and incubated 
overnight in a humidified CO2 incubator (5% CO2) at 37°C to facilitate adherence of 
macrophages (Drevot et al., 2002).   
 
3.8. Lipid raft isolation 
I pooled BAL samples from different foals to have enough number of cells to isolate lipid 
rafts. The pooling information is included in Table 3.2. The supernatant of the control (n=7) and 
vaccinated (n=8) foals on BAL1 (day 14), BAL2 (day 28) and BAL3 (day 35) from the right 
lung was discarded and the adhered macrophages were treated with 4mL trypsin 1X (Sigma-
Aldrich, Oakville, ON, Canada) at room temperature and shaken well to remove adhered 
macrophages. These macrophages were re-suspended in 10mL RPMI-1640 and centrifuged at 
400g at 4C for 10 mins. The supernatant was discarded and the pellet was suspended in 10 mL 
RPM-1640, centrifuged at 4000 rpm at 4C for 10 mins, the pellet was re-suspended in 600 μL 
of lysis buffer and further subjected to extraction by needle (30 times) and centrifugation at 400g 
for 10 mins. The supernatant (500μL) was collected in ultra centrifuge tubes (Kendro laboratory 
products, Sorvall, Newtown, USA) and 500 μL of 50 % Opti-prep density gradient medium was 
added. This was followed by (40 to 5%) step gradient of sucrose and ultra-centrifugion at 
50,000g for 2 h at 4C. Then, different layers (100uL) were collected and stored at -80C until 
further analysis. Lipid raft isolated from each pooled sample was analysed separately. Figure 3.4 
summarizes steps involved in lipid raft isolation.  
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 BAL1/day14 
 
        BAL2/day28 
 
BAL3/day35 
F (1) F (1+3) F (1+3) 
F (2+4) F (2+4) F (2+4) 
F (3+5) F (5) F (5) 
F (6+8) F (6+8+10) F (6+8) 
F (7+9+11) F (7+9+11) F (7+9+11) 
F (10+12) F (12) F (10+12) 
F (13) F (13) F (13) 
F (14) F (14) F (14) 
 
F (15) F (15) F (15) 
 
                    Table 3.2. Pooling of cells for lipid raft fractions from foal BAL 
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3.9. Protein extraction 
 
The tissue samples from normal and abnormal area from caudal dorsal region (Explained 
in Section 3.5) of the right lung of control (n=7) and vaccinated (n=8) foals were ground in 
liquid nitrogen using a sterile pestle and mortar and lysed in 250 μL of lysis buffer and allowed 
to sit on ice for 20 mins. Cell lysate was centrifuged at 10,000 rpm at 4C for 5 mins. The 
supernatant was collected and stored in -80C until further analysis.   
 
3.10. Western blotting 
Protein for Western blots was isolated from right lung tissues collected from the foals or 
the lipid raft fractions. Protein from lung tissue or lipid raft fractions was isolated from different 
treatment groups such as control (n=7) and vaccinated (n=8). The sample (45 µL) from each 
treatment was mixed with 5 μL of loading buffer (990 μL bromophenol blue, 300 μL of 10% 
SDS, 50 μL b-mercaptoethanol). Samples were denatured by boiling for 6 mins. The proteins 
were separated on 12% SDS-polyacrylamide gel using a 1X running buffer (3.3 g/L Tris base, 
14.4 g/L Glycine, 0.5 g/L SDS) at 170 V. Proteins were electroblotted onto a PVDF membrane 
(GE Healthcare life Sciences, Canada) at 100 V for 65 mins using a protein transfer buffer (3.03 
g/L Tris base, 14.4 g/L Glycine in 20% methanol). Membranes were blocked with 5% non-fat 
skimmed milk in 0.1% Tween-20 in PBS buffer (pH 7.4) for 1 h at room temperature and 
incubated overnight with flotillin-1 (goat anti-mouse Flotillin-1 antibody; 4 µg/mL; BD 
Transduction Laboratories, New Jersey, USA), ganglioside asialo-GM1 (goat anti-rabbit; 5 
µg/mL;  Abcam Cambridge, USA),   transferrin receptor (goat anti-rabbit; 5 µg/mL; Abcam), 
TLR2 (goat anti-rabbit; 1 µg/mL; Abcam Cambridge, USA) or TLR4 (goat anti-rabbit; 2 µg/mL; 
Santa Cruz Biotechnology Inc.) antibodies as recommended by the manufacturer. While we have 
characterized the TLR4 antibody for use with horse tissues (Suri et al., 2004), the other 
antibodies are not specific for the equine antigens. Unbound antibody was removed by washing 
the membrane with PBS + 0.2% Tween-20 (PBST) followed by washings with PBS (pH 7.4). 
Membranes were incubated with an appropriate horseradish peroxidase (HRP)-conjugated 
secondary antibody (polyclonal goat anti-mouse immunoglobulin (0.2 µg/mL; Dako, 
Mississauga, ON, Canada) or polyclonal goat anti-rabbit immunoglobulin (0.5 µg/mL; Dako). 
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Collect Bronchoalveolar lavage (BAL) 
                                                                        
Culture BAL cells overnight 
                                                                        
Ice cold buffer (Triton X-100) 
            
                                                                  Cell lysate 
            
Ultracentrifugation (50,000 x g) 
(5 -40 %) step gradient of sucrose 
                                                                         
                                                            Western blotting 
 
                        Figure 3.4. Protocol for lipid raft isolation  
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The unbound antibody was removed by washing with PBST and PBS (pH 7.4). The 
antigen-antibody complex was detected using a chemiluminescence kit (GE Healthcare Life 
Sciences) and membranes were exposed on X-ray films (GE Healthcare Life Sciences).  
 
 3.11. Enzyme linked–immunosorbant assay (ELISA) for tumor necrosis factor-α (TNF-α), 
Interferon gamma (IFN-γ) and Interleukin 10 (IL10)   
The expression of TNF-α protein concentration in right lung BAL supernatants at different 
time points (Table3.1) such as BALI (day 14), BAL2 (day 28), BAL3 (day 35) and lung tissue 
extracts from control (n=7) and vaccinated (n=8), at day 49 were analyzed using sandwich 
ELISA kit (Endogen, Pierce Biotechnology, inc., IL, USA) as per manufacturer’s instructions. 
These antibodies are not specific for the equine antigens. Briefly, wells of a microtitre plate 
(VWR, 96 well plates) were coated with 110 μL of rabbit anti-goat TNF antibody (diluted in 
Carbonate/Bicarbonate buffer (50 mM, pH 9.6)) and incubated overnight at 4°C. Wells were 
washed with wash buffer (0.05% Tween-20 in PBS pH 7.4), standards and samples diluted in 
reagent diluent (4% BSA in PBS pH 7.4) were added to the wells and incubated at 37°C for 1 h. 
The wells were washed with wash buffer (0.05% Tween 20 in PBS, pH 7.4) and 100 μL of 
detection antibody was added to each well after dilution with reagent diluents. The plate was 
incubated at room temperature for 30 mins. After washing wells with wash buffer, 100 μL 
streptavidin-HRP (1:400 in reagent diluent) was added and the plate was incubated at room 
temperature for 30 min.  Substrate solution (100 μL) was added and plates were incubated in the 
dark at room temperature for 20 min. On colour development, reaction was stopped by adding 
100 μL of stop solution (0.18 M sulfuric acid) to each well. Absorbance was measured at 450 nm 
using a microplate reader (BMG-Lab tech NOVO star- Microplate-Fluorometer, Biocompare, 
South San Francisco, CA, USA).  
IFN-γ protein concentration in right lung BAL supernatants at different time points (Table 
3.1) such as BALI (day 14), BAL2 (day 28), BAL3 (day 35) and lung tissue extracts from 
control (n=7) and vaccinated  (n=8), at day 49 was determined by using a sandwich ELISA kit 
(Mabtech, Cincinnati, USA) according to the manufacturer’s instructions. Wells were coated 
with 40 μL of equine IFNγ coating antibody (diluted with 10 mL PBS) and incubated overnight 
at 40C. Following washings with PBS pH 7.4, wells were blocked by adding 0.1 % BSA in PBS  
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pH 7.4 and incubated at 37C for 1 h. Wells were washed five times with PBS-Tween. Standards 
were diluted in incubation buffer and added to the wells and incubated at 37°C for 2 h. After 
removing standards and samples, wells were washed with PBS-Tween and 100 μL of detection 
antibody (mAb PAN-biotin) was added to each well after dilution with incubation buffer. The 
plate was incubated at 37°C for 1 h at room temperature. Wells were washed with PBS-Tween, 
100 μL of streptavidin-HRP (1:000 in incubation buffer) was added to each well and incubated at 
room temperature for 1 h. The wells were washed five times with PBS-Tween and 100 μL of 
substrate solution (TMB) was added to each well and incubated in the dark at room temperature 
for 20 min. On color development, the reaction was stopped by adding 100 μL of stop solution 
(0.18 M sulfuric acid) to each well and absorbance was measured at 450 nm wavelength. 
IL-10 protein concentration in right lung BAL supernatants at different time points (Table 
3.1) such as BALI (day 14), BAL2 (day 28), BAL3 (day 35) and lung tissue extracts from 
control (n=7) and vaccinated (n=8), at day 49 was determined by using a direct ELISA according 
to the R&D manufacturer’s instructions. The antigen was diluted to final concentration of 20 
µg/mL and the wells were coated with 100 μL of sample (diluted with 10 mL PBS).Then, the 
ELISA plate was incubated overnight at 40C. Following two washings with PBS pH 7.4, wells 
were blocked by adding 1 % BSA in PBS pH 7.4 and incubated at 37C for 2 h. Wells were 
washed two times with PBS. 100 μL of anti-equine IL-10 antibody was added to each well after 
dilution with blocking buffer (10 µl/mL). The plate was incubated at 37°C for 2 h, on a shaker at 
room temperature. Wells were washed four times with 200 μL of PBS. Then, wells were coated 
with 100 μL of goat anti-equine HRP conjugated secondary antibody (2µl/10mL PBS) and 
incubated at room temperature for 2 h. The wells were washed five times with PBS and 100 μL 
of substrate solution (TMB) was added to each well. On color development, the reaction was 
stopped by adding 100 μL of stop solution (0.18 M sulfuric acid) to each well and absorbance 
was measured at 450 nm wavelength. 
 
3.12.     Histopathology 
The study design was such that it did not leave any non-infected control foals at the end 
of the experiment. Therefore, the untreated control foal lung samples (n=2) provided by Dr. 
Andrew Allen, Department of Veterinary Pathology, University of Saskatchewan were used.  
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Lung tissue samples of approximately one cubic centimeter from normal and abnormal area were 
collected from caudal dorsal region (section 3) of both control (n=7) and vaccinated (n=8) 
groups. The lung tissues were fixed in 4% par formaldehyde (in PBS pH 7.4) for 24 h at 4°C. 
The tissues were transferred to PBS pH 7.4, dehydrated in ascending concentrations of ethanol 
and cleared in xylene followed by embedding in paraffin.  Sections (5 μm) were prepared from 
each tissue block and were stained with hematoxylin-eosin for histological examination.  
 
3.13. Immunohistochemistry 
      Immunohistochemistry was done on the sections obtained from the right lung of control 
(n=7) and vaccinated (n=8) foals and from the paraffin blocks of the untreated control foals 
(n=2). Tissue sections were de-waxed with xylene and rehydrated in an ethanol series. The 
sections were incubated in hydrogen peroxide (0.5% V/V in methanol) for 20 min to quench 
endogenous peroxidase followed by pepsin treatment (2 mg/mL in 0.01N HCl) for 45 min for 
antigen retrieval. Non-specific sites were blocked by incubating sections with BSA (1% in PBS 
pH 7.4; Sigma-Aldrich) for 30 min. The sections were incubated with primary antibody such as 
TLR4 (goat anti-rabbit; 6.5 µg/mL; Santa Cruz Biotechnology Inc.), TLR2 (goat anti-rabbit; 4.5 
µg/mL; Abcam,) or TNF-α (rabbit anti-goat; 0.25 µg/mL; Santa Cruz Biotechnology Inc.) 
overnight 4C. Following washings with PBS pH 7.4, sections were incubated with an 
appropriate secondary antibody as polyclonal rabbit anti-goat immunoglobulin-HRP (10 µg/mL 
BSA; Dako, Mississauga, ON, Canada), polyclonal goat anti-rabbit (10 µg/mLBSA; Dako) and 
polyclonal rabbit anti-goat immunoglobulin-HRP (10 µg/mL BSA; Dako) respectively for 30 
min. The colour development kit (Vector Laboratories, Burlington, ON, Canada) was used to 
determine the antibody reaction. Slides were counterstained with methyl green (Vector 
Laboratories Burlington, ON, Canada). Lung sections stained with only the secondary antibody, 
and those treated only with color development reagent were used as negative controls. Untreated 
control lungs were stained with rabbit anti-human von Willebrand Factor (vWF) antibody 
(6.66µg/mL), which recognizes vascular endothelium (DAKO, Mississauaga, ON, Canada). 
Then, the slides were counter-stained with methyl green (Vector Laboratories). 
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3.14. Laser confocal microscopy for lipid raft proteins 
            Lung tissue sections (5 μm) from the untreated control foals (n=2) were prepared from 
each tissue block and placed on poly L-lysine (20 KDa) 0.1 % w/v in H2O (Sigma, Aldrich) 
coated glass slides. The lung tissues were cleared in xylene and rehydrated in descending 
concentrations of ethanol followed by two washings with sterile water and three washings in 
PBS pH 7.4.  Blocking was performed in BSA (1% w/v in PBS pH 7.4) for 30 min. After one 
rinse with PBS (pH 7.4), lung tissues were probed with primary antibody mouse anti-Flotillin-1 
antibody (10 µg/mL; Abcam), goat anti-rabbit GM1 antibody (10 µg/mL; Abcam Cambridge, 
USA), goat anti-rabbit TLR4 (5 µg/mL; Santa Cruz Biotechnology Inc.), goat anti-rabbit TLR2 
(5 µg/mL; Abcam,) antibodies.  After three washings with PBS (pH 7.4), slides were incubated 
with an appropriate secondary antibody diluted in 1 % BSA , anti-mouse IgG conjugated to 
fluorescence isothiocyanate (FITC; 40 µg/mL) or anti-rabbit IgG conjugated to Cy5 (2.5 µg/mL ; 
Millipore, Bedford, USA) in the dark for 1 hour at room temperature. This was followed by three 
washings with PBS (pH 7.4) for 10 min each. The slides were mounted with Prolong Gold 
antifade mounting reagent (Invitrogen) and examined under a confocal microscope (Leica model 
TCS SP5, Wetzler, Germany). Images were processed using Leica IM1000. 
        
3.15. Statistical analysis 
All statistical analyses were performed using Prism™ software (version 2.0; GraphPad 
Software Inc., San Diego, CA, USA). The groups were compared at specific time points using 
the Wilcoxon Rank Sum test.  Results are expressed as the median values ± SD. The P value ≤ 
0.02 was considered significant.  
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CHAPTER 4: RESULTS 
 
4.1.      Influx of inflammatory cells 
 
There was no significant difference in total number of cells (p=0.3687) in BALF from the 
right side of lung in control and the vaccinated groups at different sampling days (Figure 4.1). 
Cytospin from BAL taken from right lung of control (n=7) and vaccinated (n=8) foals at day 14, 
day 28 and day 35 were prepared (Figure 4.2) and differential cell count was done (Table 4.1). 
Also, the protein concentration (p=0.2482) estimated by Bio-Rad Protein Assay, based on the 
method of Bradford, in BAL supernatant did not differ significantly (Figure 4.3) between the 
groups. 
 The gross appearance (surface and cut) of lungs from the control and the vaccinated 
groups was not consistent. On post-mortem evaluation, in the control group, lungs were 
classified as unaffected in 2/7 foals (28.6%; foals 2 and 6), moderately affected in 3/7 foals 
(42.8%; foals 4, 8, 12), and severely affected in 2/7 foals (28.6 %; foals 10, 14). In the 
vaccinated foal group, lungs were classified as unaffected in 4/8 foals (50 %; foals 3, 5, 9,13) 
and moderately affected in 4/8 foals (50 %; foals 1, 7, 11, 15) (Table 4.2). Lungs from some of 
the foals clearly showed granulomatous lesions lung (Figure 4.4A) compared to some of the 
vaccinated foals (Figure 4.4B). Similar variation was observed on the cut surface of lungs 
collected from different control foals (Figure 4.4C, E) and the vaccinated foals (Figure 4.4D, F). 
There were no differences in the gross lesions between the groups (Figure 4.4G).  
Lung sections from untreated control (non-vaccinated, non-infected) foals obtained from 
the department of Veterinary Pathology and stained with hematoxylin-eosin (H&E) revealed 
normal morphology of alveolar septa (Figure 4.5 A) and bronchus (Figure 4.5 D). The control 
foal group showed marked septal congestion and influx of inflammatory cells in alveoli (Figure 
4.5 B) accompained by mucus plug inside the bronchus (Figure 4.5 E). However, similar results 
were examined in vaccinated foal group in alveoli (Figure 4.5 C) and bronchus (Figure 4.5 F). 
The bronchial epithelium showed prominent cilia along with stratified appearance of epithelium 
in untreated control foal (Figure 4.5 G) compared to altered epithelium accompained by fuzzy 
and matted cilia in control (Figure 4.5 H) and vaccinated (Figure 4.5 I) foal groups. Marked 
congestion of blood vessels along with thickening of the tunica externa was appreciated in 
vaccinated (Figure 4.6C) and control foal (Figure 4.6B) groups compared to untreated foal group  
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(Figure 4.6A). Also, histopathology studies indicated advanced granulomatous lesion 
accompanied by deposition of edematous fluid, fibrin and marked vasculature changes and the 
loss of normal architecture of lung in control (Figure 4.7A) and vaccinated (Figure 4.7B) foal 
groups. Further examination of granulomas from control foal (Figure 4.7C) and vaccinated 
(Figure 4.7D) foal groups revealed accumulation of inflammatory cells such as macrophages, 
lymphocytes and giant cells. Considering variation in the foals within the same group, there 
appeared to be no differences in the inflammation between the control and the vaccinated groups. 
 
4.2.    Western blotting and immunohistologic expression of Toll-like receptors (TLR2 and 
TLR4) in foal lung tissue 
           Western blotting revealed expression of TLR2 (89kDa) and TLR4 (89kDa) in lung tissue 
extracts from vaccinated group and the control (Figure 4.8A) foal group. The 48 KDa band of ß-
actin, expressed in both the treatment groups showed equal loading of protein in each lane. 
Densitometric comparison of Western blots showed significant increase in the expression of the 
TLR2 (Figure 4.8B) but not of TLR4 (Figure 4.8C) in the lung extracts from the vaccinated foals 
compared to the control foals.  
           Untreated control foal lung sections stained with only secondary antibody lacked any 
color reaction while those incubated with the von Willebrand Factor antibody showed staining of 
vascular endothelium (Figure 4.9A). Immunohistology revealed increased expression of TLR2 in 
the alveolar septa of the control and the vaccinated foals compared to the untreated control foals 
(Figure 4.9B). The expression of TLR2 in the airways and the large blood vessels remained 
nearly similar although there was an appearance of reduced expression in the vaccinated group 
(Figure 4.9C) compared to other treatment groups. TLR4 expression was faint in the alveolar 
septa in the lungs of untreated control foals but was increased in the septa of control and 
especially the vaccinated foals (Figure 4.10A). While the vascular expression of TLR4 appeared 
similar in all the groups, the airway epithelial expression increased in the vaccinated foals 
(Figure 4.10B). Alveolar septa of the untreated control foals showed weak staining for TNFα 
compared to the control and the vaccinated foals (Figure 4.11A). Vascular and airway epithelial 
expression of TNFα was also increased in the lungs of vaccinated foals compared to the 
untreated control and the control foals (Figure 4.11B). Overall, there was similar expression of 
TLR4, TLR2 and TNF in the lungs of the control and the vaccinated foals. 
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4.3.      Expression of inflammatory cytokines 
 
4.3.1    Tumor necrosis factor-alpha (TNF α) expression  
 
TNFα protein concentration was assessed with sandwich ELISA both on BAL and lung 
extracts from control and vaccinated groups. The foals in the vaccinated group showed higher 
concentrations of TNFα in BAL (p=0.02) compared to the control foals on day 28 (Figure 
4.12A). However, there were no differences in TNFα concentrations in lung extracts from the 
two groups (p=0.9451) (Figure 4.12B).  
 
4.3.2    Interferon gamma (IFNγ) protein expression 
 
  IFNγ protein concentration was analyzed in BAL (Figure 4.13A) and lung extract Figure 
4.13B) by sandwich ELISA. There was no significant difference in IFNγ concentration in BAL 
(p=0.8211) and lung extract (p=0.1672) between both the groups. 
 
  4.3.3    Interleukin 10 (IL-10) protein expression  
 IL-10 protein concentration was examined in BAL and lung extract by direct ELISA in 
control and vaccinated groups at different sampling days. In BAL, there were no significant 
differences (p=0.8937) in the expression of IL-10 between the groups (Figure 4.14A).  However, 
significantly lower concentrations of IL-10 were observed in lung extracts from the vaccinated 
group compared to the control group (p=0.0172) (Figure 4.14B).  
  
4.4.      Lipid raft isolation protocol from bronchao-alveolar lavage macrophages 
A method of lipid raft isolation from equine alveolar macrophages was developed by 
pooling foal BAL and preparing cell lysates from a minimum of 1X107cells in Triton X-100, a 
non-ionic detergent and further separation by sucrose (5-40%) step gradient. Lipid rafts were 
obtained at the interphase of 20 and 25 % sucrose. 
 
4.5.     Identification of lipid raft and non- lipid raft proteins 
          The pooled samples from the foals BAL cells were used for lipid raft extraction. Each of 
the pooled samples (Table 3.2) at different sampling days was Western blotted and screened for 
the presence or absence of lipid raft resident proteins (Flotillin-1 and GM1) and non-lipid raft  
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protein – transferrin receptor (Tfr). Western blot results showed the expression of lipid raft and 
non-lipid raft proteins in foal BAL cells collected on day 14 from control and vaccinated foals 
(Figure 4.15 A) . In control foals (Figure 4.15A), the faint expression of a 48 kDa band for 
Flotillin-1 was appreciated in fractions 2, 3, 4 while stronger bands for  Flotillin-1 were seen in  
fractions 7, 8 and 9. However, in vaccinated foals (Figure 4.15A), the expression of Flotillin-1 
was appreciated from fraction 4 to 9 and the bands were more intense in fractions 6 to 9 of the 
lipid raft. Western blot results also showed GM1 as a 13 kDa band from fractions 4 to 9 in 
control group (Figure 4.15A) and from fractions 6 to 9 in vaccinated group (Figure 4.15A).  
Transferrin receptor (TfR) is a characteristic non-raft protein and it was detected in fractions 1, 2 
and 3 but not in fractions 7, 8 and 9 in control foals (Figure 4.15A) and in fractions 1 and 2 in 
vaccinated foal group (Figure 4.15A). 
   Similarly, foal BAL supernatants collected on day 28 were pooled from control foals 
and vaccinated foals were screened for the presence or absence of lipid raft resident proteins 
(Flotillin-1 and GM1) and non-lipid raft protein, transferrin receptor (Tfr). In control foals 
(Figure 4.15 B), the expression of a 48 kDa band for Flotillin-1 was appreciated from fraction 2 
to 9 as it was getting more intense towards the lipid raft fractions. However, in vaccinated foals 
(Figure 4.15 B), the expression for Flotillin-1 was also seen in almost all the fractions but strong 
expression was in fractions 5 to 8. Furthermore, GM1 as a 13 kDa band was expressed strongly 
in the 7th  fraction as compared to fractions 8 and 9 in control foal group (Figure 4.15B) and from 
fractions 6 to 9 in vaccinated group (Figure 4.15B). Transferrin receptor (TfR) protein was 
detected in fractions 1, 2, 3 and 4 in both control foals (Figure 4.15B) and in vaccinated foal 
group (Figure 4.15B). 
   Again on day 35, foal BAL supernatants were pooled from control foals and vaccinated 
foals, respectively, and were screened for the presence or absence of lipid raft and non-lipid raft 
proteins. In control foals and vaccinated foal groups (Figure 4.15 C), the expression of a 48 kDa 
band for Flotillin-1 and GM1 was appreciated from fraction 6 to 9. Transferrin receptor (TfR) 
was detected in fractions 1, 2, 3 in non lipid raft fractions in both control foals (Figure 4.15C) 
and in the vaccinated foal group (Figure 4.15C).The expression of both lipid raft resident 
proteins and non-lipid raft protein were well appreciated in vaccinated group compared to 
control group on day 35. 
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 I probed untreated foal lung tissues for the expression of Flotillin-1 and GM1 with 
confocal microscopy. The data showed co-localization for Flotillin-1 and GM1 in lung sections 
(Figure 4.16).  
 
4.6.       Association of lipid rafts with TLR2 and TLR4 in BAL and foal lung tissue  
In the present investigation, I examined whether lipid rafts co-localize with the TLRs. 
Western blot results indicate TLR2 and TLR4 as 89 kDa bands by probing with appropriate 
antibodies at different sampling days. Pooled foal BAL supernatants collected on day 14 (Figure 
4.17A upper panel) showed TLR2 as 89 kDa band from fractions 1 to 9. The expression of TLR2 
was appreciated in lipid raft fractions 7 to 9 fractions in the vaccinated group. On day 28 (Figure 
4.17A middle panel), in case of the control foal group, TLR2 expression was seen from fractions 
5 to 9 but again strongly towards lipid raft fractions. In the vaccinated foal group, TLR2 
expression was appreciated in lipid raft fractions 8 to 9. Similarly, on day 35 (Figure 4.17A 
lower panel), TLR2 in the controls was associated with fractions 6 to 9, but intense expression 
was seen in 7th fraction. In vaccinated foal group, TLR2 expression remained the same as on day 
28, as it was limited to fraction 8 and 9.   
Pooled foal BAL cells collected on day 14 (Figure 4.17B upper panel) were western 
blotted and the results showed faint expression of TLR4 as 89 kDa band from fractions 1 to 9. 
Similarly, the expression of TLR4 was appreciated as faint bands in lipid raft fractions 7 to 9 in 
the vaccinated group. On day 28 (Figure 4.17B middle panel), TLR4 expression was seen in 
fraction 5 to 9 in the control foals and fractions 7 to 9 in the vaccinated group. On day 35 (Figure 
4.17B lower panel), in the control foal group, TLR4 was associated with fractions 5 to 9. 
However, in the vaccinated foal group, TLR4 expression was limited to fractions 7 to 9. The 
pattern of TLR4 on day 28 and day 35 remained almost the same, but stronger expression was 
appreciated on day 35. The overall picture indicated that both TLR2 and TLR4 represented 
similar results on different sampling days in both treatment groups. 
The relationship between TLRs and lipid rafts was further studied by confocal 
microscopy in untreated foals (n=4) by using various combinations of antibodies. Confocal 
microscopy data depicts that both Flotillin-1 and TLR2 (Figure 4.18) colocalise in the alveolar  
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septum (Figure 4.18, upper panel) and in airway epithelium (Figure 4.18, lower panel). Similar 
results were obtained TLR4 and Flotillin-1 (Figure 4.19).  
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Day/group Macrophages 
(%) 
Segmented 
neutrophils 
(%) 
Lymphocytes 
(%) 
 
Monocytes 
(%) 
 
Eosinophils 
(%) 
 
BAL 14 
 
     
Control 85± 2 5± 3 5± 2 1±1 0±0 
Vaccinated 84± 7 
 
5±3 5± 4 2± 1 0± 0 
BAL 28 
 
     
Control 90±2 2± 2 5± 2 2± 1 0± 0 
Vaccinated 90±3 2±0 5± 3 2± 1 0± 0 
BAL 35 
 
     
control 81± 7 14±8 3± 1 0± 0 0± 0 
vaccinated 84±9 11±10 4±2 0± 0  0±0 
 
Table 4.1: Differential cell counts of Control (n=7) and Vaccinated (n=8) foal BAL supernatant. 
Data is presented as mean ± SD 
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Control 
group 
 
 
 
Lung lesion 
 
 
Score 
  
 
Vaccine 
group 
 
 
 
Lung lesion 
 
 
 
Score 
 
F2 Normal 0 F3  Normal  0 
F6  Normal  0 F5  
 
Normal  0 
F4 Moderate  2 F9  
 
Normal  0 
F8  Moderate  2 F13  
 
Normal  0 
F12 Moderate  2 F1  
 
Moderate  2 
F10  Severe 3 F7  Moderate  2 
F11  
 
Moderate  2 
F14  Severe 3 F15  
 
Moderate  2 
 
 
Table 4.2: Post-mortem lung lesions (right lung) in control (n=7) and vaccinated (n=8) foals. 
There were no significant differences between the groups. Foals lung lesions scored 
as described in Materials and Methods.
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Figure 4.1. Total number of cells in the right side foal BAL collected from control  (n=7) 
and vaccinated  (n=8) groups at different sampling days.There was no 
significant difference (p=0.3687) between groups. Horizontal line indicates 
median.  
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Figure 4.2.   Cytospins of the foal BAL supernatants from control and vaccinated foals at 
different sampling days showed generally similar distribution of alveolar 
macrophages (single arrows) and neutrophils (double arrows). X40 
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Figure 4.3.  Protein concentration in foal BAL supernatant recovered from control (n=7) 
and vaccinated (n=8) groups at different sampling days.There was no 
significant difference (p=0.2482) between groups. Horizontal line indicates 
median. 
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Figure 4.4. Gross evaluation (upper panel) and cut sections (lower panel) of the lungs at day  
49 showing lesions in lungs from control (A, C, E) and the vaccinated (B, D, F).  
While control lungs (C) from one foal show more pathology than those from a 
vaccinated foal (D), the lungs from another control foal (E) show much reduced 
lesions. G shows no differences in the lung pathology between the groups. 
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Figure 4.5. Histopathology: Foal lung sections stained with hematoxylin-eosin (H&E) 
revealed no inflammation in alveoli (A) and bronchus (D) in untreated control 
foals. Whereas, marked septal congestion and influx of inflammatory cells in 
alveoli (B,C) accompained by mucus plug inside the bronchus (E,F) was 
appreciated in control and vaccinated foals respectively.The bronchial 
epithelium showed prominent erect cilia in untreated control foal (G) as 
compared to fuzzy and matted clia in control (H) and vaccinated (I) groups. 
Overall there were no differences between the control and the vaccinated foals 
lungs. A-C and G-I:X40 . D-F:X10. 
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Figure 4.6. Histopathological studies: Foal lung section stained with hematoxylin-eosin  
(H&E) from untreated control foal (A) showed minimal vasculature changes 
as compared to marked congestion of blood vessels and thickening of tunica 
externa (marked by arrow) layer of blood vessel in control (B) foal and 
vaccinated (C) foal group. A-C:X40 
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Figure 4.7. Histopathological studies: Foal lung section stained with hematoxylin-eosin  
(H&E) from control foal (A) and vaccinated (B) foal groups revealed large 
aggregates of inflammatory cells accompanied with deposition of edematous 
fluid, vasculature changes and the loss of normal architecture of lung. Further 
examination of granulomas from control foal (C) and vaccinated (D) foal 
groups revealed influx of inflammatory cells such as macrophages (marked by 
arrows), lymphocytes and giant cells .A-B: X10.C-D:X40. 
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                     Figure 4.8. Western blot showing the expression of TLR2 (A, B) and TLR4 (A, C) 
in   foal (N=7/group) in lung extracts recovered control and vaccinated 
foal groups on day 49. TLR2 but not TLR4 expression was 
significantly higher (*) in the lung extracts of vaccinated foals. 
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Figure 4.9A. Lung section stained without primary antibody did not show 
any staining while those incubated with vWF antibody 
revealed staining of vascular endothelium (arrows). X40 
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Figure 4.9B.   Lung section stained with TLR2 antibody showed weak staining 
(arrows) in alveolar septum of untreated control foal lung 
compared to the lungs from the control and the vaccinated foals 
which showed overall similar staining. All X40. 
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Figure 4.9C. Lung section stained with TLR2 antibody showed nearly similar reaction 
(arrows) in the vascular endothelium of blood vessels and the epithelium of 
airways of the untreated control and the control foals but the expression 
appeared less intense in the vaccinated foals. All X40. 
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Figure 4.10A. Lung section stained with TLR4 antibody showed weak staining (arrows) 
in alveolar septum of untreated control foal lung compared to the lungs 
from the control and the vaccinated foals. There appeared some increase 
in staining of TLR4 in the lungs from vaccinated foals. All X40. 
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Figure 4.10B. Lung section stained with TLR4 antibody showed nearly similar reaction 
(arrows) in the vascular endothelium of blood vessels. However, the TLR4 
reaction appeared more intense in the epithelium of the airways of the 
vaccinated foals compared to other groups. All X40. 
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Figure 4.11A. Lung section stained with TNFα antibody showed weak staining (arrows) in 
alveolar septum of untreated control foals compared to the lungs from the 
control and the vaccinated foals. All X40. 
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Figure 4.11B. Lung section stained with TNFα antibody showed more intense staining 
(arrows) in the vascular endothelium of blood vessels and the epithelium of 
the airways of the vaccinated foals compared to other two groups. All X40. 
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Figure 4.12A. TNFα concentration as determined with ELISA on foal BAL supernatant 
recovered from control (n=7) and vaccinated (n=8) groups at different 
sampling days.There was significant difference (p=0.02) (indicated by *) 
between control and vaccinated groups at day 28. Horizontal line 
indicates median. 
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Day 49 
Figure 4.12B. TNFα concentration as determined with ELISA on foal lung extract 
recovered from control (n=7) and vaccinated (n=8) groups at day49.There 
was no significant difference (p=0.9457) between groups. Horizontal line 
indicates median. 
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Figure 4.13A. IFNγ concentration as determined with ELISA on foal BAL supernatant 
recovered from control (n=7) and vaccinated (n=8) groups at different 
sampling days.There was no significant difference (p=0.8211) between 
groups. Horizontal line indicates median. 
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Figure 4.13B. IFNγ concentration as determined with ELISA on foal lung extract 
recovered from control (n=7) and vaccinated (n=8) groups at day 49. 
There was no significant difference (p=0.1672) between groups. 
Horizontal line indicates median. 
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Figure 4.14A. IL-10 concentration as determined with ELISA on foal BAL supernatant 
recovered from foals in control (n=7) and vaccinated (n=8) groups at 
different sampling days.There was no significant difference (p=0.8937) 
between groups. Horizontal line indicates median. 
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Figure 4.14B. IL-10 concentration as determined with ELISA on foal lung extract 
recovered from foals in control (n=7) and vaccinated (n=8) groups at day 
49. There was significant difference (p=0.0172) (indicated by *) between 
control and vaccinated groups. Horizontal line indicates median. 
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Figure 4.15A. Western blot showing the expression of lipid raft proteins (Flotillin-1 and GM1) 
and non-lipid raft protein (Transferrin receptor-Tfr) in various membrane 
fractions isolated from foal BAL cells on day 14.  
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Figure 4.15B. Western blot showing the expression of lipid raft proteins (Flotillin-1and GM1) 
    and non-lipid raft protein (Transferrin receptor-Tfr) in various fractions of plasma 
membranes isolated from foal BAL supernatant on day 28.  
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Figure 4.15C. Western blot showing the expression of lipid raft proteins (Flotillin-1and GM1) 
   and non-lipid raft protein (Transferrin receptor-Tfr) in various fractions of plasma 
membranes isolated from foal BAL supernatantat day 35 . 
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Figure 4.16. Co-localisation of lipid raft proteins (Flotillin-1 and GM1) in untreated control 
foal lung tissue by confocal microscopy (Bar=100 μm) 
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Figure 4.17A.  Western blot showing the expression of TLR2 in various fractions of 
plasma membrane isolated from foal BAL at indicated sampling days. 
TLR2 was generally restricted to the lipid raft fractions (7-9) in the 
vaccinated foals. 
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Figure 4.17B.   Western blot showing the expression of TLR4  in fractions of plasma 
membrane obtained from foal BAL cells from control and vaccinated foal 
groups at different sampling days. TLR4 was generally restricted to lipid 
raft fractions (7-9).  
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Figure 4.18. Expression of Flotillin-1 and TLR2 in untreated control foal lung tissue (day 
49) by confocal microscopy. Flotillin-1 and TLR2 colocalises in the alveolar 
septa (upper panel) and the airway epithelium (lower panel). (Bar=100μm) 
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Figure 4.19. Expression of Flotillin-1 and TLR4 in untreated control foal lung tissue (day 49) by 
confocal microscopy. Flotillin-1 and TLR4 colocalises in the plasma membrane in 
cells (Bar=100μm) 
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CHAPTER 5: DISCUSSION 
 
 
In this study, I have compared the lung inflammation in the control (non-vaccinated and 
challenged) and vaccinated (vaccinated and challenged) foals. I also provide the first protocol to 
isolate lipid rafts from equine cells. Gross and histological data showed lung inflammation in 
both control and vaccinated foals. Immunohistology showed altered expression of TLR2, TLR4 
and TNF on alveolar septa, airway epithelium and endothelium in both groups compared to the 
untreated control lungs. Vaccinated foals showed increased expression of TNF in the BAL 
fluid, decreased expression of IL-10 in lung tissues and increased association of TLR4 and TLR2 
with the lipid rafts isolated from alveolar macrophages.  
Young foals are susceptible to R. equi infection between 1-6 months of age (Prescott, 
1991; Giguere et al., 1997; Chaffin et al., 2003). The establishment of R. equi infection is a 
process that is probably ‘ignored’ by the immune system and has clinical consequences for the 
host. The mechanisms of establishment of R. equi infections in young foals are poorly 
understood and probably are intertwined with the development of the immune system in the 
lung. Because of the clinical consequences of R. equi infection there has been increasing interest 
in understanding the basic immune responses in young foals with an aim to elucidate the 
mechanisms of establishment of infections. Furthermore, a better understanding of basic immune 
responses will lead to development of effective vaccines against R. equi infection.  
In the present study, I studied inflammatory responses in the lungs of R. equi infected 
foals and vaccinated foals to determine the efficacy of the vaccine. The inflammation in the lung 
was studied through the use of BAL, histopathology, ELISA and immunohistology. Although the 
central objective of the study was to evaluate the efficacy of the vaccine against R. equi 
infection, one of the weaknesses of the study is the lack of BAL and lung tissue homogenate data 
from non-infected control foals. We partially overcame this problem by using paraffin-embedded 
lung tissues from normal foals which were obtained from the department of Veterinary 
Pathology as controls for histopathological and immunohistological studies.  
Broncho-alveolar lavage is a powerful tool to study lung pathophysiology in horses and 
other species and provides  a sample for quantification of inflammatory cells and inflammatory 
mediators in the supernatant of BAL. In many instances the isolated cells can be further used to 
analyze their inflammatory capacities in vitro (Kawasaki et al., 2006; Feng et al., 2008; 
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Hoffman, 2008;Couetil et al., 1999; Couetil et al., 2001; Sanchez et al., 2005; Allen et al., 2006; 
Riihimaki et al., 2008).  
Lung inflammation is characterized by the migration of inflammatory cells into the 
alveolar spaces (Parbhakar et al., 2005). The cell migration is a complex process that includes 
activation and expression of cytokines on endothelial and epithelial cells (Janardhan et al., 2004). 
These cellular and molecular processes result in migration of inflammatory cells such as 
neutrophils and macrophages into alveolar spaces in response to lung infections with bacteria. 
Analyses of BAL are useful in evaluating the migration of inflammatory cells into the alveolar 
spaces. The data from this study showed no differences in total cell numbers in the BAL between 
the control and vaccinated group at different sampling days to suggest that the vaccination did 
not alter the inflammatory response induced by R. equi infection.  
The accumulation of inflammatory cells in the alveolar spaces is a terminal step in their 
migration from the lung microvessels. It is possible that more inflammatory cells are trapped in 
the interstitum and the blood vessels in the lung which may not be evident from the analyses of 
BAL. Therefore, we performed gross and histological examination of the lungs from both 
groups. There appeared to be some differences in the extent and nature of gross lesions in the 
lungs. But it is difficult to quantify the lesions at the gross level of examination. Semi 
quantitative scoring of gross sections cut from the lungs did not show any differences in lung 
inflammation between the two groups. However, compared to the lung sections from the 
untreated control foals, both the groups showed gross and histological signs of lung 
inflammation. Based on the BAL, gross and histological analyses, it appears that R. equi induced 
lung inflammation was not modulated by the vaccination. 
The manifestation of lung inflammation through changes in the BAL and tissue 
architecture is an advanced step, which is initiated following sophisticated changes in the 
expression of various inflammatory molecules and activation of receptors of the immune system. 
Toll-like receptors (TLRs) are transmembrane proteins and germline coded receptors present on 
the cells of the immune system (Lu et al., 2008).  TLRs are a part of  the conserved IL-1 
superfamily and act as sensors against microbial conserved pathogen associated molecular 
patterns such as LPS, lipotechoic acid, CpG, peptidoglycans and unmethylated DNA on the 
surface of pathogens (Takeda et al., 2003; Takeuchi et al., 2001; Abreu et al., 2005; Suri et al.,  
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2006). TLR signaling results in cell activation, expression of adhesion molecules and secretion 
of inflammatory cytokines (Suri et al., 2006). To date, 11 TLRs have been found in humans and 
13 TLRs have been found in mice, that were isolated based on their ligand specificity (Sheedy et 
al., 2007; Uno et al., 2007). CD14, a 55KDa protein mediates the recognisation of LPS (Pugin et 
al., 1993; Gioannini et al., 2007; Miyake, 2007). CD14 is present both in and outside of the lipid 
raft in normal conditions. Previously, expression of TLR4 has been described in the endothelium, 
pulmonary intravascular macrophages and the airway epithelium of the horse (Suri et al., 2006). 
In the study presented here,  immunohistology showed increased expression of TLR2 and TLR4 
in the alveolar septum of the lungs of both control and vaccinated groups compared to the 
untreated control foal lungs. Interestingly, Western blots also showed increased expression of 
TLR2 but not TLR4 in the lung extracts from the vaccinated foals compared to the control foals. 
Previously, the engagement of a particular TLR by its ligand has been shown to alter the 
expression of other TLR in the horse lungs (Suri et al., 2006). It is also expected that failure to 
signal the presence of R. equi or any other infectious agent in the lungs of newly born foals may 
result in the establishment of infection. The weak expression of TLR2 and TLR4 in the alveolar 
septum, which is critical for the sensing of bacteria and signaling across the blood-air barrier, 
may underlie the failure to mount an effective immune response against R. equi. The increased 
expression of TLR2 and TLR4 following bacterial challenge with or without vaccination 
indicates some effect on the maturation of the immune system in the lungs of the foals.  It is 
possible that even though R. equi infection up-regulated the expression of TLRs, especially 
TLR2, the immune response may be one step behind the infection and may not be able to fully 
clear the infection. In future studies, it may be useful to examine the expression of TLR4 and 
TLR2 on the BAL cells with flow cytometry and examine the role of these receptors in their 
responses to R. equi infection in vitro.   
 The activation of cells through receptors such as TLR4 and TLR2 finally leads to the 
expression of inflammatory mediators such as TNF, IFN and IL-10. Cytokines play critical 
roles in inflammation and their fine balance is important in clearing infection without causing too 
much tissue pathology. I examined the expression of TNF with immunohistology in the lung 
tissues and that of TNF, IFN, IL-10 with ELISA in foal BAL and lung extracts. Because the 
protein is the functional end product of gene expression and sole reliance on the mRNA data can 
lead to faulty conclusions, I decided to examine the protein expression of selected cytokines.  
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Due to the limitations of the experiment design, it was not possible to compare the BAL 
changes in the control or vaccinated groups with the age-matched untreated control foals. 
Therefore, the BAL collected on day 14, 28 and 35 from the control and the vaccinated foals 
were compared with each other and the lung tissues collected after euthanasia on day 49 were 
analyzed. Although there are many cytokines that play roles in inflammation, I selected IFN for 
its established role as a immune-modulator and development of foal immunity (Merant et al., 
2008), TNF for its central pro-inflammatory role in bacterial infections and lung inflammation 
and IL- 10 for its role as an anti-inflammatory cytokine (Charavaryamath et al., 2006). There 
were no differences in the expression of IFN in foal BAL collected on different sampling days 
or the lung tissue extracts obtained after euthanasia on day 49. Immunohistology appeared to 
show increased expression of TNF in lung tissues especially in the alveolar septum and the 
airway epithelium, from both the control and the vaccinated groups compared to untreated 
control foals. There was also significantly higher concentration of this cytokine in BAL from the 
vaccinated foals compared to the control foals at day 28. Interestingly, there were reduced 
concentrations of IL-10 in lung extracts of the vaccinated foals compared to the control foals. 
Because of lack of BAL data from untreated control foals in the present study, it is difficult to 
compare with the data from previous studies that showed an increase in expression of pro-
inflammatory cytokines such as TNFα and IL-1 and anti-inflammatory cytokine such as IL-10, 
and 1L-12, while expression of IFNγ and IL-12 remained unaltered in foals infected with a 
virulence plasmid strain of R. equi (Giguere et al., 1999). Nevertheless, increased expression of 
the pro-inflammatory cytokine TNF in BAL on day 28 and reduced expression of the anti-
inflammatory cytokine IL-10 in lung extracts on day 49 in the vaccinated foals would suggest an 
increased immune response to R. equi challenge. Indirectly this would suggest a priming effect 
of the vaccine on the lung cells such as macrophages leading to a more robust inflammation in 
the lungs in response to the challenge. It however, needs to be stated that balanced rather than 
exuberant inflammation is a desired outcome in an infection. These differences in the cytokine 
expression between the two groups may not be profound enough to alter the degree of pathology 
in the lungs of the foals. The data require further studies to clarify the impact of vaccination on 
the expression of inflammatory molecules. Despite some differences in the cytokine expression,  
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the present study shows that the vaccine does not prevent lung pathology induced by R. equi 
infection.  
 
Lipid rafts are detergent resistant membranes, enriched in cholesterol, sphingolipids and 
transmembrane proteins and make up about 50% of the plasma membrane (Helms et al., 2004; 
Hao et al., 2001; Pike, 2003). Recently, the role of lipid rafts in cell signaling has been 
elucidated through various studies. It has been shown that various microbes such as bacteria, 
viruses and parasites used lipid rafts as a platform or port of entry into the cell. The microbes 
alter lipid raft dynamics thereby “hijacking” them and thus, preventing immune response against 
the invading pathogens (Manes et al., 2003). Innate immune receptors such as TLRs are 
localized in the lipid rafts to facilitate signaling through them (Triantafilou et al., 2002; 
Dolganiuc et al., 2006). It is possible that R. equi infection is established in lung cells of foals 
because of the failure of sequestration of TLRs in the lipid rafts. Because there are no data on the 
isolation of lipid rafts from the equine cells, I developed a protocol to prepare lipid rafts from 
BAL cells collected from the foals. The newly developed method for the isolation of lipid rafts 
from BAL cells is faster and more efficient compared to the previous methods which are more 
complex and time consuming (Martens et al., 2001; Gaus et al., 2003; de Mello Coelho et al., 
2004; Sleight et al., 2005). The data show isolation of plasma membrane factions from 1 X 107 
BAL cells. Because there were not enough cells in the BAL taken from a single foal, I had to 
pool the BAL from 2-3 foals to have enough cells for successful isolation of the rafts. I took care 
to pool BAL samples from the foals within the same treatment group. The identity of the lipid 
rafts was established through localization of Flotillin-1 (48kDa) and GM1 (13kDa), which are 
resident proteins of lipid rafts, with Western blots. The fractions were also probed for the 
presence of non-lipid raft proteins such as transferrin receptor (17kDa). The comparison of lipid 
rafts from BAL cells from the control foals with the vaccinated showed no differences in the 
distribution of Flotillin-1, GM1 and tranferrin receptor proteins. I also show the first localization 
of lipid raft proteins in the lung tissues of untreated control foals with confocal microscopy. The 
lipid raft proteins were localized in the alveolar septum, airway epithelium and the vascular 
endothelium in the lungs.  
Lipid rafts from BAL collected on day 14 from the control foals showed Flotillin-1 and 
GM-1 in fractions 3-9. However, the BAL taken from the vaccinated foals on day 14 showed  
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these proteins generally in fractions 6-9. The expression of these proteins in lipid rafts taken 
from BAL collected on day 35 was more intense in fractions 6-9 of the vaccinated foals 
compared to the control foals. These data suggest the possibility that the first vaccination may 
have led to activation of cells to segregate lipid rafts while the macrophages from the naïve foals 
may not be able to form lipid rafts. This interpretation may suggest a subtle effect of vaccination 
on the cell signaling platforms i.e. lipid rafts of macrophages. 
After successfully establishing the raft isolating and identification protocol, I investigated 
whether TLR4 and TLR2 colocalize with lipid raft fractions because for effective cell signaling 
TLRs must be sequestered into lipid rafts. While TLR2 was localized in both non-lipid raft and 
lipid raft fractions of BAL macrophages of control foals on day 14, it was detected in lipid raft 
fractions on day 28 and day 35. In contrast, TLR2 was detected in fractions 7-9 on day 14, 28 
and 35 of vaccinated foals. It appears that the first vaccination affected the localization of TLR2 
in lipid raft fractions and is in line with the segregation of lipid raft and non-lipid raft fractions.  
Nearly similar observations were made for TLR4. TLR4 presence in lipid raft fraction was not in 
agreement with previous studies, where TLR4 was found in non-lipid raft region of the plasma 
membrane (Triantafilou et al., 2002; Soong et al., 2004). It seems that the vaccination may have 
have had a general effect on the ability of BAL cells to sequester receptors in lipid rafts of the 
cell membrane. The confocal microscopy data showed co-localization of TLR2 and TLR4 with 
Flotillin-1 in the airway epithelium, vascular endothelium and alveolar septum. Taken together, 
these data show association of TLR2 and TLR4 with lipid raft fractions. Also, the data indicate 
that BAL macrophages from newly born foals lack the capacity to develop lipid rafts and also to 
segregate TLR2 and TLR4 into lipid rafts. Interestingly, the first vaccination did induce 
association of TLR2 with lipid rafts in macrophages. Considering the role of TLR2 in R. equi 
cell signaling (Darrah et al., 2004), these data show that exposure to vaccination and the age may 
play important roles in the ability of the foals to launch an effective immune response, and point 
out the subtle effects of vaccination. The increased association of TLR4 and TLR2 with lipid 
rafts of the foals may also offer an explanation for more pronounced inflammation in the lungs of 
vaccinated foals as indicated by increased expression of TNF and reduced expression of IL-10. 
These being the first set of data on the localization of TLRs with lipid rafts, there is a need for 
further studies.  
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CHAPTER 6: SUMMARY 
 
 
The data from the experiments reported in this thesis show similar degree of 
inflammation in the lungs of R. equi infected foals with or without vaccination. The 
immunohistologic data appeared to show increased expression of TLR4, TLR2 and TNF in the 
lungs of both the infected groups (with or without vaccination) compared to the untreated control 
foal group. There were increased concentrations of TNF in BAL and reduced concentrations of 
IL- 10 in lung extracts of vaccinated foals compared to control foals. Western blots showed 
expression of increased expression of TLR2 but not TLR4 in lung extracts of the vaccinated 
foals compared to the control foals. Taken together, these data suggest similar levels of 
pathology in the lungs but indicate higher degree of immune response in lungs of foals that were 
vaccinated before challenge with R. equi. Lipid rafts sequester receptors such as TLRs and act as 
signaling platforms. Therefore, I developed a protocol to isolate lipid rafts from foal BAL cells 
to investigate distribution of TLR4 and TLR2. The data indicate that lung macrophages from 
naïve newly born foals may not have efficient lipid rafts and also may be unable to sequester 
TLR2 and TLR4 to generate effective cell activation and immune response. Combination of 
increased expression of TLR2 and TLR4 and increased association of these molecules with the 
lipid raft fractions in the vaccinated foals does suggest subtle effects of the vaccination. These 
effects do require further investigation.  
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CHAPTER 7:  CONCLUSION 
 
The data from the experiments do not support the hypothesis that vaccination reduces lung 
inflammation in response to R. equi challenge. The data do support the hypothesis that lipid rafts 
associate with TLR2 and TLR4 in BAL cells of the vaccinated foals but not the control foals.  
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CHAPTER 8: FUTURE STUDIES 
 
To further understand the role of lipid rafts in R. equi infection, it is important to pursue 
the cellular and molecular effects upon depletion of lipid rafts. It may be important to explore 
proteins other than TLRs that are involved in pathogen entry inside the cells. Lastly, to explore if 
lipid raft proteins are restricted to lipid raft region only or they shift to non-lipid raft region upon 
infection. It would also be interesting to examine the expression of TLR4 and TLR2 on the BAL 
cells with flow cytometry and examine the role of these receptors in their responses to R. equi 
infection in vitro. 
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